680 filings
Page 26 of 34
6-K
xc38h3j6fn1yarzxjx
10 Feb 16
RedHill Biopharma Receives Notice of Allowance of Fifth U.S. Patent Covering RHB-104 Phase III Crohn’s Disease Program
12:00am
6-K
240jo 3i6iynfxrzm5d
9 Feb 16
RedHill Biopharma Issues Letter to Shareholders
12:00am
6-K
583q5d vjdf
8 Feb 16
RedHill Biopharma Announces Collaboration With Germany’s Fraunhofer Institute for Oncology Drug RP101
12:00am
6-K
z5zai1fg jzl
2 Feb 16
RedHill Biopharma to Present at the 18th Annual BIO CEO & Investor Conference
12:00am
6-K
ejs3qijdb 64mffga
12 Jan 16
Current report (foreign)
12:00am
6-K
9vevpi
5 Jan 16
RedHill Biopharma to Present at Biotech Showcase 2016
12:00am
6-K
985df8b7dz3ue2m
30 Dec 15
RedHill Biopharma Announces Appointment of Micha Ben Chorin as Chief Financial Officer
12:00am
6-K
3diq5c
15 Dec 15
RedHill Biopharma Announces Appointment of Rick D. Scruggs to Board of Directors
12:00am
6-K
e8okphj b86wdhga
30 Nov 15
Form 6-K Filing Document
12:00am
6-K
7evs9rahe11f3v66vo
30 Nov 15
Form 6-K Filing Document
12:00am
6-K
5v9xe6gw
12 Nov 15
Form 6-K Filing Document
12:00am
6-K
kcl3js ocaou6a
9 Nov 15
Current report (foreign)
12:00am
6-K
a1vyljm
9 Nov 15
Form 6-K Filing Document
12:00am
6-K
5qso st93o
29 Oct 15
Form 6-K Filing Document
12:00am
6-K
7dtes z8f2zb4p60
29 Oct 15
Current report (foreign)
12:00am
6-K
h4zmcw39
28 Oct 15
Form 6-K Filing Document
12:00am
6-K
f9e chz0bb3u63nfqj
26 Oct 15
Form 6-K Filing Document
12:00am
6-K
bhkx2
22 Oct 15
Form 6-K Filing Document
12:00am
6-K
qjk7j1iqbot4t4lop
22 Oct 15
Form 6-K Filing Document
12:00am
6-K
wktd 33t7e
22 Oct 15
Form 6-K Filing Document
12:00am